Achieve Life Sciences
Develops cytisinicline for nicotine dependence across smoking-cessation and vaping-cessation programs.
$8.26
After-hours close+0.15 (+1.85%)
At close$8.11(−0.86%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 20.97%21.52M sharesInsiders 0.89%913.6K sharesOther 78.14%80.22M shares
Shares outstanding 102.66M · Float 87.47M · 85.2% free float
Institutions13F, as of Mar 31, 2026
86 holders · 21.52M shares · 17 new positions · 37 increased · 20 reduced · 14 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Franklin Resources Inc | 4.37M | 4.26% | 0 | May 13, 2026 |
| Propel Bio Management, LLC | 3.79M | 3.69% | 0 | May 14, 2026 |
| Vanguard Capital Management LLC | 2.20M | 2.15% | +2.20Mnew | May 15, 2026 |
| Simplify Asset Management Inc. | 1.18M | 1.15% | 0 | Apr 27, 2026 |
| Millennium Management LLC | 1.08M | 1.05% | −281.8K | May 15, 2026 |
| Marshall Wace, LLP | 1.02M | 0.99% | 0 | May 15, 2026 |
| LPL Financial LLC | 728.4K | 0.71% | +95.3K | May 6, 2026 |
| Nantahala Capital Management, LLC | 648.9K | 0.63% | 0 | May 15, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| TPG GP A, LLCincl. Jon Winkelried, James G. Coulter | 12.60% | 13.76M | 13D | Apr 24, 2026 ↗ |
| Logos Global Management LP | 9.99% | 10.54M | 13G | Aug 17, 2026 ↗ |
| venBio Global Strategic GP V, LLCincl. venBio Global Strategic Fund V, L.P. | 9.99% | 10.74M | 13D | Apr 27, 2026 ↗ |
| Paradigm BioCapital Advisors LP | 9.20% | 9.90M | 13G | Apr 24, 2026 ↗ |
| Frazier Life Sciences Public Fund, L.P. | 6.50% | 6.63M | 13G | Apr 24, 2026 ↗ |
| Franklin Resources, Inc. | 6.20% | 6.37M | 13G | May 7, 2026 ↗ |
| Alyeska Investment Group, L.P. | 5.60% | 2.98M | 13G | Nov 14, 2025 ↗ |
| JANUS HENDERSON GROUP Ltd. | 5.40% | 5.50M | 13G | Aug 13, 2026 ↗ |
| Venrock Healthcare Capital Partners III, L.P. | 5.20% | 5.50M | 13G | Apr 24, 2026 ↗ |
| BlackRock, Inc. | 5.10% | 5.27M | 13G | Jul 27, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| TPG GP A, LLC | 10 percent owner | 6.88M | 6.70% | Apr 24, 2026 |
| Thomas Braxton King | director | 315.1K | 0.31% | Sep 8, 2025 |
| Richard Alistair Stewart | director | 208.2K | 0.20% | Aug 21, 2026 |
| Mark K. Oki | officer: Chief Financial Officer | 127.9K | 0.12% | Sep 22, 2025 |
| Cindy Jacobs | officer: President & CMO | 115.6K | 0.11% | Sep 8, 2025 |
| Jaime Xinos | officer: Chief Commercial Officer | 74.4K | 0.07% | Sep 8, 2025 |
| Mark Lawrence Rubinstein | officer: Chief Medical Officer | 39.6K | 0.04% | Jan 12, 2026 |
| Jerry Wan | officer: Principal Accounting Officer | 32.7K | 0.03% | Sep 8, 2025 |
10 ten-percent owners hold 6.93M shares by Form 4 — the 13D/G table above shows those stakes, the figure above counts officers and directors only · 16 people have not refiled in the last 18 months (3.60M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 19, 2026 | Richard Alistair Stewartdirector | Sale | 20,626 | $8.49 | 208,249 |
| Sep 18, 2025 | Richard Alistair Stewartdirector, officer: Chief Executive Officer | Sale | 129,501 | $2.92 | 228,875 |
| Sep 18, 2025 | Mark K. Okiofficer: Chief Financial Officer | Sale | 50,060 | $2.92 | 127,940 |
| Sep 4, 2025 | Jaime Xinosofficer: Chief Commercial Officer | Sale | 20,854 | $2.77 | 74,432 |
| Sep 4, 2025 | Cindy Jacobsofficer: President & CMO | Sale | 27,629 | $2.77 | 115,585 |
| Sep 4, 2025 | Thomas Braxton Kingdirector | Sale | 139,858 | $2.77 | 315,142 |
| Sep 4, 2025 | Jerry Wanofficer: Principal Accounting Officer | Sale | 14,070 | $2.77 | 32,694 |
CongressHouse and Senate disclosures
Not reported.